Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
azd3759 (1 trial)
erlotinib (tarceva) (1 trial)
gefitinib (iressa) (1 trial)
Neoplasm Metastasis (Phase 3)
Neoplasms, Second Primary (Phase 3)
Trials (1 total)
Trial APIs (3 total)